Cargando…

Expression of SARS‐CoV‐2 entry factors in human oral tissue

The distribution of cells expressing SARS‐CoV‐2 entry factor angiotensin‐converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in human oral tissues were tested. The investigation was conducted with normal flesh tissue and paraffin‐embedded specimens. The ACE2 and TMPRSS2 expressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawa, Yoshihiko, Ibaragi, Soichiro, Okui, Tatsuo, Yamashita, Junro, Ikebe, Tetsuro, Harada, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013449/
https://www.ncbi.nlm.nih.gov/pubmed/33421967
http://dx.doi.org/10.1111/joa.13391
_version_ 1783673490858049536
author Sawa, Yoshihiko
Ibaragi, Soichiro
Okui, Tatsuo
Yamashita, Junro
Ikebe, Tetsuro
Harada, Hiroyuki
author_facet Sawa, Yoshihiko
Ibaragi, Soichiro
Okui, Tatsuo
Yamashita, Junro
Ikebe, Tetsuro
Harada, Hiroyuki
author_sort Sawa, Yoshihiko
collection PubMed
description The distribution of cells expressing SARS‐CoV‐2 entry factor angiotensin‐converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in human oral tissues were tested. The investigation was conducted with normal flesh tissue and paraffin‐embedded specimens. The ACE2 and TMPRSS2 expression was detected with all subjects in the normal mucosa of the keratinized stratified squamous epithelia of the tongue and non‐keratinized stratified squamous epithelia of the lip and cheek. It was found that ACE2 is expressed in the cytoplasm and on the cell membrane mainly in the stratum granulosum of the epithelia while the TMPRSS2 is strongly expressed on the cell membrane mainly in the stratum granulosum and stratum spinosum, but not in the stratum basale. Antibodies’ reactions for ACE2 and TMPRSS2 were not observed in the nuclei or keratin layer. The expression of ACE2 and TMPRSS2 in the oral epithelia appears to be general, and the expression was also observed in the mucous and serous acini of the labial glands. The SARS‐CoV‐2 may transiently attach to the oral mucosa and the minor salivary glands which are present under all of the oral mucosa. The oral cavity can be considered an important organ for SARS‐CoV‐2 attachment and may provide a preventive medical avenue to guard against COVID‐19 by preventing saliva from scattering.
format Online
Article
Text
id pubmed-8013449
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80134492021-04-01 Expression of SARS‐CoV‐2 entry factors in human oral tissue Sawa, Yoshihiko Ibaragi, Soichiro Okui, Tatsuo Yamashita, Junro Ikebe, Tetsuro Harada, Hiroyuki J Anat Original Papers The distribution of cells expressing SARS‐CoV‐2 entry factor angiotensin‐converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in human oral tissues were tested. The investigation was conducted with normal flesh tissue and paraffin‐embedded specimens. The ACE2 and TMPRSS2 expression was detected with all subjects in the normal mucosa of the keratinized stratified squamous epithelia of the tongue and non‐keratinized stratified squamous epithelia of the lip and cheek. It was found that ACE2 is expressed in the cytoplasm and on the cell membrane mainly in the stratum granulosum of the epithelia while the TMPRSS2 is strongly expressed on the cell membrane mainly in the stratum granulosum and stratum spinosum, but not in the stratum basale. Antibodies’ reactions for ACE2 and TMPRSS2 were not observed in the nuclei or keratin layer. The expression of ACE2 and TMPRSS2 in the oral epithelia appears to be general, and the expression was also observed in the mucous and serous acini of the labial glands. The SARS‐CoV‐2 may transiently attach to the oral mucosa and the minor salivary glands which are present under all of the oral mucosa. The oral cavity can be considered an important organ for SARS‐CoV‐2 attachment and may provide a preventive medical avenue to guard against COVID‐19 by preventing saliva from scattering. John Wiley and Sons Inc. 2021-01-09 2021-06 /pmc/articles/PMC8013449/ /pubmed/33421967 http://dx.doi.org/10.1111/joa.13391 Text en © 2021 The Authors. Journal of Anatomy published by John Wiley & Sons Ltd on behalf of Anatomical Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Papers
Sawa, Yoshihiko
Ibaragi, Soichiro
Okui, Tatsuo
Yamashita, Junro
Ikebe, Tetsuro
Harada, Hiroyuki
Expression of SARS‐CoV‐2 entry factors in human oral tissue
title Expression of SARS‐CoV‐2 entry factors in human oral tissue
title_full Expression of SARS‐CoV‐2 entry factors in human oral tissue
title_fullStr Expression of SARS‐CoV‐2 entry factors in human oral tissue
title_full_unstemmed Expression of SARS‐CoV‐2 entry factors in human oral tissue
title_short Expression of SARS‐CoV‐2 entry factors in human oral tissue
title_sort expression of sars‐cov‐2 entry factors in human oral tissue
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013449/
https://www.ncbi.nlm.nih.gov/pubmed/33421967
http://dx.doi.org/10.1111/joa.13391
work_keys_str_mv AT sawayoshihiko expressionofsarscov2entryfactorsinhumanoraltissue
AT ibaragisoichiro expressionofsarscov2entryfactorsinhumanoraltissue
AT okuitatsuo expressionofsarscov2entryfactorsinhumanoraltissue
AT yamashitajunro expressionofsarscov2entryfactorsinhumanoraltissue
AT ikebetetsuro expressionofsarscov2entryfactorsinhumanoraltissue
AT haradahiroyuki expressionofsarscov2entryfactorsinhumanoraltissue